Century Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Century Therapeutics, Inc. (IPSC) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 24.82 thousand shares as of 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-03-12
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 24.82K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 49.42K shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 49.47K shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 49.42K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2024-12-31 | 24.82K shares 10-K · filed 2026-03-12 |
| 2023-12-31 | 49.42K shares 10-K · filed 2025-03-19 |
| 2023-09-30 | 49.47K shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 49.42K shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 49.47K shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 193.03K shares 10-K · filed 2024-03-14 |
| 2022-09-30 | 247.78K shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 384.21K shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 520.63K shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 681.79K shares 10-K · filed 2023-03-16 |
| 2021-09-30 | 818.21K shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 871.18K shares 10-Q · filed 2021-08-12 |
| 2020-12-31 | 1.05M shares 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |